Navigation Links
Low-level Laser Therapy Clinics' Partnership Targets Helping People Nationwide
Date:11/27/2007

LOS ANGELES, Calif., Nov. 27 /PRNewswire/ -- Los Angeles, California based clinics, Aventi Hair Therapy and Freedom Laser Therapy, are joining forces to create a unique partnership for their nationwide licensing expansion of their health & cosmetic services.

(Photo: http://www.newscom.com/cgi-bin/prnh/20071127/CLTU058 )

Aventi is the largest nationwide practitioner of Laser Hair Therapy, a safe procedure that assists in stopping hair loss, increasing hair thickness and boosting hair growth. Freedom Laser Therapy is the industry leader specializing in helping smokers break their nicotine addictions and lose weight through the usage of Low-level laser therapy. The laser devices used by each clinic are classified as non-significant risks by the FDA. Aventi and Freedom have treated thousands of Los Angeles residents to repair excessive hair loss and to quit smoking; and they are now in the process of expanding their branded services nationwide.

Freedom and Aventi each have established, reputable brand names for their companies from years of receiving patient referrals. President of Freedom Laser Therapy, Craig Nabat, states, "Aventi and Freedom have a parallel goal of informing America about the many health and cosmetic positive effects of the 30-year old low-level laser therapy procedures. Sixteen Aventi Freedom Laser Therapy treatment locations will be established by January 1st, 2008 in Southern California. Our plan is to establish 50 treatment sites within the next 12 months. This will be accomplished by producing a 30-minute nationwide television program, which will continually educate the public about the potential benefits of laser therapy. To date there has been no constant nationwide promotion from any one clinic or brand in the United States promoting the effects of low-level laser therapy."

The two clinics will now use their brand strengths to e
'/>"/>

SOURCE Freedom Laser Therapy
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Laser blasts viruses in blood
2. Skin Cooling After Laser Treatment Could Leave Marks
3. Prize for Cutting-Edge Laser Innovations
4. VNUS Medicals Patent Lawsuit Against Laser Competitors to Proceed to Trial
5. OmniGuide Announces Launch of LightPath(TM) CO2 Laser Fiber
6. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
7. Alma Lasers Answers Lumenis Complaint
8. Laser Energetics Delivers BrightStar(TM) Alexandrite Laser to Fortune 50 Defense Company
9. BioHorizons Introduces Its New Tapered Internal Implants Featuring Laser-Lok(R) Microgrooves
10. Imaging Diagnostic Systems to Present Laser Breast Imaging Clinical Results at the 2007 Radiological Society of North America Scientific Assembly
11. Vision restoration therapy shown to improve brain activity in brain injured patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...ommunications announces a highly effective and unc...truggling to make an economic recovery. , ...fears is the type of challenge that could send ail... to Dr. David Benton, business growth expert and a... – The Rfactor Intensive . “Fear is...
(Date:11/25/2009)...RNewswire/-SentinelleMedicalInc.,aleadingmanufactu...andCalgaryScientificInc.,aleadingproviderofsoftwar...egis(TM)Breast4DAdvancedVisualizationsoftware. ,...printWebclientbasedmedicalimagingofferinginthemark...zero-footprintaccess-requiringnosoftwaredownload,a...
(Date:11/25/2009)...wire/--TheBayAreaAirQualityManagementDistrictisiss... Alert forThursday,November26,2009whichbansbu...bothindoorsandoutdoors. ,, "Cold,stillweatherwi...kBroadbent,executiveofficeroftheAirDistrict."We,re...ghborsandfellowcommunitymembersthisThanksgiving,an...
(Date:11/25/2009)...ure? This simple question has been the focus of i...d gene Modulates High Blood Pressure in Mice & Men...le question has been the focus of intense research...st time established a link between a novel gene, p...s in mice as well as humans. The studies were dire...
(Date:11/25/2009)...gical symptoms, study finds , , WEDNESD...effects are among the potential problems faced by ...treated with cisplatin-based chemotherapy, a new s...egian men treated for unilateral testicular cancer...p survey conducted from 1998 to 2002. , The res...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
...egory Laslo will travel to Washington, D.C., Sunda...t with congressional leaders and gain their suppor...earch toward a cure for epilepsy. , , Rundlett, 1...th support from Abbott. The program rallies young ...
... Phoenix, AZ, will travel to Washington, D.C., Su...meet with congressional leaders and gain their sup...research toward a cure for epilepsy. , , McArthur...nd funded by Abbott Laboratories. The program rall...
...use from intimate partners spent 42 percent more o...rding to a long-term study of more than 3,000 wome... The study revealed that women who suffered physic...cal and emotional pain it causes, domestic violenc...
...ces, Inc. announced today that it has provided $19...spital in Mountain View, California. The five-year...y of Siemens Medical Solutions equipment which wil...e than 40 years, El Camino Hospital has been servi...
...ty, IA will travel to Washington, D.C., Sunday, Ma...h congressional leaders and gain their support for... toward a cure for epilepsy. , , Carlson, 16, is ... by Abbott Laboratories. The program rallies young...
...Inc., the premier cancer diagnostics company and t...ay announced the appointment of Grady Barnes, Ph.D...o Fujirebio Diagnostics with 25 years of diagnosti...dian Bioscience. , , As Chief Scientific Officer,...
Other Medicine News:Health News:Maryland Youths Share Epilepsy Message on Capitol Hill 2Health News:Arizona Youth Shares Epilepsy Message on Capitol Hill 2Health News:Physical abuse raises women's health costs over 40 percent 2Health News:Siemens Financial Services, Inc. Announces Completion of Tax-Exempt Financing With El Camino Hospital 2Health News:Siemens Financial Services, Inc. Announces Completion of Tax-Exempt Financing With El Camino Hospital 3Health News:Iowa Youth Shares Epilepsy Message on Capitol Hill 2Health News:Fujirebio Diagnostics Appoints Grady Barnes as Chief Scientific Officer 2
(Date:11/25/2009)...inker.comannouncesthatanewmarketresearchreportisav...t-AGlobalMarketPerspective ,, http://www.rep...lobal-Market-Perspective.html ,, Risinginciden...nationsisaprincipalfactorinfluencinggrowthinthemam...eastcancerhasallowedwomentocomeforwardfortheiryear...
(Date:11/25/2009)...e/--SwissrayInternational,Inc.aleadingmanufacturer...todaythatitsoperationshavebeenacquiredbyaprivateSw...,smedicalimagingbrand.Theacquisitionincludedallass...entory.After25yearsofsuccessandgrowthSwissrayisnow...ntswithstableandsteadygrowth. ,, "Swissrayhaslo...
(Date:11/25/2009)...l/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicecom...ivesurgicaltreatmentsforthespine,announcedtodaytha...,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfocu...ny,sproductsandwillincludecommentsfrommanagementfo...umbersare1-877-407-4018fordomesticcallersand1-201-...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Swissray International Announces New Ownership 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 1OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 2OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 3OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 4OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 5LA BioMed study finds higher survival rate among intoxicated trauma patients 58613 1Algae and pollen grains provide evidence of remarkably warm period in Antarcticas history 10205 1Algae and pollen grains provide evidence of remarkably warm period in Antarcticas history 10205 2Algae and pollen grains provide evidence of remarkably warm period in Antarcticas history 10205 3Algae and pollen grains provide evidence of remarkably warm period in Antarcticas history 10205 4
...teria to Help Facilitate EHR Adoption in Small, Am..., March 3 The Certification Commission for Heal...rally recognized body for testing and certifying e...will develop dermatology-specific functionality cr... in part a response to an application from the Ame...
...IS, March 3 Novexel, a speciality pharmaceutical,...f novel antibiotics,designed to overcome the signi...unces today that its most advanced injectable anti... beta lactamase inhibitor, NXL104, with the,well e...has entered a second,Phase II clinical trial. , ...
Other Medicine Technology:Certification Commission for Healthcare Information Technology to Develop Dermatology-Specific Functionality Criteria for Electronic Health Record (EHR) Technology 2Novexel's NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs) 2Novexel's NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs) 3Novexel's NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs) 4
USA Series MICRO-6L Semi-Rigid Ureteroscope
...he ACMI DUR-8 Elite's 8.7 Fr shaft reaches into th...iding complete intrarenal access, even reaching th... covering and working channel ease insertion of bo...stable shaft construction, tight-bend radius tip, ...
...he ACMI USA Series DUR-8 Durable Flexible Ureteros...e entire intrarenal collecting system with little ... secondary deflection allow complete intrarenal ac...ction facilitates access to the proximal ureter an...
S-Series Cystourethroscope Standard Obturator
Medicine Products: